| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.007 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |